Anti-Histone H2B (Acetyl-Lys5) antibody produced in rabbit

Name	Anti-Histone H2B (Acetyl-Lys5) antibody produced in rabbit
Supplier	Sigma-Aldrich
Catalog	SAB4502227
Prices	$335.50
Sizes	100 µg
Host	Rabbit
Clonality	Polyclonal
Applications	IHC ICC/IF
Species Reactivities	Human, Mouse
Antigen	Synthesized peptide derived from human Histone H2B (Acetyl-Lys5)
Description	Rabbit Polyclonal
Gene	H2BFS
Conjugate	unconjugated
Supplier Page	Shop

Product images

<B>Immunohistochemistry</B><BR/>Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>): <B>Cat. No. SAB4502227</B>: Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>) antibody. Cells on the left were treated with the Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>) antibody. Cells on the right (negative control) were treated with both Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>) antibody and the synthesized immunogen peptide.

Immunohistochemistry
Anti-Histone H2B (Acetyl-Lys⁵): Cat. No. SAB4502227: Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using Anti-Histone H2B (Acetyl-Lys⁵) antibody. Cells on the left were treated with the Anti-Histone H2B (Acetyl-Lys⁵) antibody. Cells on the right (negative control) were treated with both Anti-Histone H2B (Acetyl-Lys⁵) antibody and the synthesized immunogen peptide.

<B>Immunofluorescence</B><BR/>Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>): <B>Cat. No. SAB4502227</B>: Immunofluorescence of HeLa cells using Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>) antibody. Cells on the left were treated with the Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>) antibody. Cells on the right (negative control) were treated with both Anti-Histone H2B (Acetyl-Lys<SUP>5</SUP>) antibody and the synthesized immunogen peptide.

Immunofluorescence
Anti-Histone H2B (Acetyl-Lys⁵): Cat. No. SAB4502227: Immunofluorescence of HeLa cells using Anti-Histone H2B (Acetyl-Lys⁵) antibody. Cells on the left were treated with the Anti-Histone H2B (Acetyl-Lys⁵) antibody. Cells on the right (negative control) were treated with both Anti-Histone H2B (Acetyl-Lys⁵) antibody and the synthesized immunogen peptide.